Publisert 13.06.2018

Regenics AS Annual Report 2017

Regenics post a small positive 2017 result with topline in excess of 0.047 mill NOK. 

Regenics post a small positive annual result with topline in excess of 0.047 mill NOK. 

Annual Report 2017  (password)  

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.